Collection de copies de pièces sur l'histoire de France, formée par François DE CAMPS, abbé de Signy (1723). II PROVINCES. 57 Lyon et Lyonnais.

« De la souveraineté des rois de France sur la ville et le comté de Lion » (fol. 2, 93, 120) : pièces justificatives, 942-1320 (132, 183). — Lettre critique sur l'Histoire civile ou consulaire de la ville de Lyon du P. Menestrier (90). — Primatie de Lyon (186). Extraits « ex cartulario episcopatus Diensis, quod est conventus fratrum Minimorum Parisiensium, » 1158-1229 (193). Diplômes de l'empereur Frédéric II, copies extraites des archives du Domaine royal en Languedoc, arm. B (196). Inventaire des chartes du Trésor relatives au Lyonnais (218).

Collection de copies de pièces sur l'histoire de France, connue sous le nom de Portefeuilles de Fontanieu, formée par Gaspard-Moyse DE FONTANIEU (1767). PREMIÈRE PARTIE — Histoire par règnes. 149-150 Charles VIII (1494-1498).

Contient : Lettre de Louis, duc d'Orléans [Louis XII] sur la mort de Jean Galéas, duc de Milan (1497) ; copie du temps

Catalogue de recueils d'ornements... composant la collection de M. P. G...

[Vente (Art). 1928-06-19. Paris]

Report on a review of selected general and application controls over the Iowa Department of Human Services’ Iowa Collection and Reporting System (ICAR) for the period April 1, 2013 through April 24, 2013 and April 1, 2014 through April 29, 2014

Report on a review of selected general and application controls over the Iowa Department of Human Services’ Iowa Collection and Reporting System (ICAR) for the period April 1, 2013 through April 24, 2013 and April 1, 2014 through April 29, 2014

Rationale and design of a randomized, double-blind, parallel-group study of terutroban 30 mg/day versus aspirin 100 mg/day in stroke patients: the prevention of cerebrovascular and cardiovascular events of ischemic origin with terutroban in patients with a history of ischemic stroke or transient ischemic attack (PERFORM) study.

BACKGROUND: Ischemic stroke is the leading cause of mortality worldwide and a major contributor to neurological disability and dementia. Terutroban is a specific TP receptor antagonist with antithrombotic, antivasoconstrictive, and antiatherosclerotic properties, which may be of interest for the secondary prevention of ischemic stroke. This article describes the rationale and design of the Prevention of cerebrovascular and cardiovascular Events of ischemic origin with teRutroban in patients with a history oF ischemic strOke or tRansient ischeMic Attack (PERFORM) Study, which aims to demonstrate the superiority of the efficacy of terutroban versus aspirin in secondary prevention of cerebrovascular and cardiovascular events. METHODS AND RESULTS: The PERFORM Study is a multicenter, randomized, double-blind, parallel-group study being carried out in 802 centers in 46 countries. The study population includes patients aged > or =55 years, having suffered an ischemic stroke (< or =3 months) or a transient ischemic attack (< or =8 days). Participants are randomly allocated to terutroban (30 mg/day) or aspirin (100 mg/day). The primary efficacy endpoint is a composite of ischemic stroke (fatal or nonfatal), myocardial infarction (fatal or nonfatal), or other vascular death (excluding hemorrhagic death of any origin). Safety is being evaluated by assessing hemorrhagic events. Follow-up is expected to last for 2-4 years. Assuming a relative risk reduction of 13%, the expected number of primary events is 2,340. To obtain statistical power of 90%, this requires inclusion of at least 18,000 patients in this event-driven trial. The first patient was randomized in February 2006. CONCLUSIONS: The PERFORM Study will explore the benefits and safety of terutroban in secondary cardiovascular prevention after a cerebral ischemic event.

Use of Remote Sensing for Collection of Data Elements for Linear Referencing Systems, 2001

This report evaluates the use of remotely sensed images in implementing the Iowa DOT LRS that is currently in the stages of system architecture. The Iowa Department of Transportation is investing a significant amount of time and resources into creation of a linear referencing system (LRS). A significant portion of the effort in implementing the system will be creation of a datum, which includes geographically locating anchor points and then measuring anchor section distances between those anchor points. Currently, system architecture and evaluation of different data collection methods to establish the LRS datum is being performed for the DOT by an outside consulting team.